LRRC37A17P

Across TCGA pan-cancer cohorts, LRRC37A17P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LRRC37A17P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LRRC37A17P RNA is associated with better overall survival. In most high-consensus cancer types, elevated LRRC37A17P expression acts as an unfavorable survival marker, although some lineages such as KIRC and LGG show a favorable association.

KIRC, LGG, and CESC are the cancer types where LRRC37A17P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.760	0.558	<.001	50	view →
LGG	DFS	Tertile	All	0.824	0.672	<.001	36	view →
CESC	DFS	Quartile	All	0.622	0.845	.002	20	view →
UCS	OS	Median	IV	0.673	0.248	.033	18	view →
HNSC	DFS	Quartile	IV	0.712	0.513	.005	17	view →
COAD	DFS	Median	All	0.716	0.838	.003	14	view →
LUSC	DFS	Quartile	III,IV	0.319	0.951	.002	12	view →
ACC	DFS	Quartile	All	0.415	0.763	.011	11	view →
BRCA	OS	Tertile	IV	0.650	0.136	.016	9	view →
READ	OS	Quartile	II,III,IV	0.874	0.330	.014	9	view →
THCA	OS	Median	II,III,IV	0.849	0.979	.011	9	view →
OV	OS	Quartile	III,IV	0.233	0.372	.015	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LRRC37A17P–KIRC (OS)

Open the KIRC breakdown →